Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study

Advances in neuro-oncology imaging

(2017) Karl-Josef Langen et al.   Nature Reviews Neurology

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

(2017) Norbert Galldiks et al.   NeuroImage-Clinical

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma

(2016) Jens Göttler et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

DynamicO-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy

(2016) Garry Ceccon et al.   NEURO-ONCOLOGY

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

(2016) Nathalie L. Albert et al.   NEURO-ONCOLOGY

MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis

(2016) Praneil Patel et al.   NEURO-ONCOLOGY

Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics

(2016) Jurgita Usinskiene et al.   NEURORADIOLOGY

Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET

(2015) Lucile Janvier et al.   CLINICAL NUCLEAR MEDICINE

Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience

(2015) Otto M. Henriksen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging

(2015) Osamu Manabe et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans

(2015) Nathalie L. Albert et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?

(2015) Norbert Galldiks et al.   NEURO-ONCOLOGY

Performance of18F-FET versus18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis

(2015) Vincent Dunet et al.   NEURO-ONCOLOGY

System l amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-l-tyrosine (FET)

(2014) A. Habermeier et al.   AMINO ACIDS

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

(2014) K. M. Schmainda et al.   NEURO-ONCOLOGY

Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements

(2012) S N Friedman et al.   BRITISH JOURNAL OF RADIOLOGY

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

(2012) Nathalie L. Jansen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

(2012) Norbert Galldiks et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Multimodal imaging utilising integrated MR-PET for human brain tumour assessment

(2012) Irene Neuner et al.   EUROPEAN RADIOLOGY

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas

(2012) N. L. Jansen et al.   NEURO-ONCOLOGY

Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging

(2012) R. F. Barajas et al.   NEURO-ONCOLOGY

Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion

(2011) A. G. Sorensen et al.   CANCER RESEARCH

High resolution BrainPET combined with simultaneous MRI

(2011) H. Herzog et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy

(2011) Marc D. Piroth et al.   RADIOTHERAPY AND ONCOLOGY

Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery

(2010) Stella Blasel et al.   JOURNAL OF NEURO-ONCOLOGY

Early metabolic responses in temozolomide treated low-grade glioma patients

(2009) Matthias Wyss et al.   JOURNAL OF NEURO-ONCOLOGY

RETRACTED ARTICLE: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging

(2009) H. R. Arvinda et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature

(2009) Kaisorn L. Chaichana et al.   NEUROLOGICAL RESEARCH

Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI

(2008) Nicolás Fayed et al.   EUROPEAN JOURNAL OF RADIOLOGY

Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma

(2008) Stephan Ulmer et al.   JOURNAL OF NEURO-ONCOLOGY